Capecitabine (Xeloda) in combination with oxaliplatin: a phase I, dose-escalation study in patients with advanced or metastatic solid tumors.


Autoria(s): Diaz-Rubio, E.; Evans, T.R.J.; Taberno, J.; Cassidy, J.; Sastre, J.; Eatock, Martin; Bisset, D.; Regueiro, P.; Baselga, J.
Data(s)

01/01/2002

Identificador

http://pure.qub.ac.uk/portal/en/publications/capecitabine-xeloda-in-combination-with-oxaliplatin-a-phase-i-doseescalation-study-in-patients-with-advanced-or-metastatic-solid-tumors(d19b8e06-e8bd-4af3-8370-581d4bf500ba).html

http://dx.doi.org/10.1093/annonc/mdf065

http://www.scopus.com/inward/record.url?scp=0035987216&partnerID=8YFLogxK

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Diaz-Rubio , E , Evans , T R J , Taberno , J , Cassidy , J , Sastre , J , Eatock , M , Bisset , D , Regueiro , P & Baselga , J 2002 , ' Capecitabine (Xeloda) in combination with oxaliplatin: a phase I, dose-escalation study in patients with advanced or metastatic solid tumors. ' Annals of Oncology , vol 13(4) , no. 4 , pp. 558-565 . DOI: 10.1093/annonc/mdf065

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/1300/1306 #Cancer Research #/dk/atira/pure/subjectarea/asjc/2700/2730 #Oncology
Tipo

article